MARKER THERAPEUTICS, INC. Net Cash Provided by (Used in) Discontinued Operations
MARKER THERAPEUTICS, INC. (MRKR) reported Net Cash Provided by (Used in) Discontinued Operations of -$2.90 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInDiscontinuedOperations · last filed 2024-05-15
- MARKER THERAPEUTICS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2023-03-31 was -$2.90M.
| Period end | Net Cash Provided by (Used in) Discontinued Operations 3 month |
|---|---|
| 2023-03-31 | -$2.90M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |